OXILAN (ioxilan) injection is a third-generation nonionic contrast medium offered by Guerbet in the U.S. It is a contrast agent used by radiologists, interventional radiologists and interventional cardiologists because of unique properties. It has low osmolality and viscosities among nonionic monomers in the U.S., which contributes to better patient outcomes such as patient comfort during intra-arterial injection and addresses physicians’ needs such as excellent image quality and easier injections.
OXILAN has a unique molecular structure which includes a hydrophobic region to promote molecular aggregation, thereby reducing the osmolality. Only those nonionic monomers that contain hydrophobic regions can achieve significantly lower solution osmolalities at diagnostically useful concentrations. This unique molecular design also features a terminal hydrophilic group, which results in reduced risk of side effects from binding with biological structures. The hydrophilic group also increases the solubility of the molecule.


Related Content

News | Interventional Radiology

November 3, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time November 03, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

October 17, 2023 — Halo Precision Diagnostics, a leader in early disease detection using precision diagnostics, today ...

Time October 17, 2023
arrow
News | Ultrasound Imaging

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...

Time September 15, 2023
arrow
News | Prostate Cancer

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 28, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...

Time July 27, 2023
arrow
News | Contrast Media

July 25, 2023 — Bracco Imaging has issued a statement on new results published in the journal Radiology which found that ...

Time July 25, 2023
arrow
News | Contrast Media

June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society ...

Time June 20, 2023
arrow
News | Contrast Media

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
News | Contrast Media

May 15, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced that ...

Time May 15, 2023
arrow
Feature | Contrast Media | By Christine Book

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...

Time May 03, 2023
arrow
Subscribe Now